Company profile for GeneFab

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

GeneFab is a contract manufacturing and synthetic biology biofoundry focused on cell and gene therapies. GeneFab was formed in 2023 with a vision to combine industry-leading expertise in synthetic biology with advanced cGMP capabilities in order to accelerate the development and commercialization of genetic medicines. GeneFab offers its customers an extensive technology platform and know-how that spans early-stage product desi...
GeneFab is a contract manufacturing and synthetic biology biofoundry focused on cell and gene therapies. GeneFab was formed in 2023 with a vision to combine industry-leading expertise in synthetic biology with advanced cGMP capabilities in order to accelerate the development and commercialization of genetic medicines. GeneFab offers its customers an extensive technology platform and know-how that spans early-stage product design, technical development, and cGMP-compliant production.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
1430 Harbor Bay Pkwy Alameda, CA 94502
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.contractpharma.com/breaking-news/genefab-regcell-partner-for-treg-therapy-manufacturing-in-the-u-s/

CONTRACTPHARMA
07 May 2025

https://www.globenewswire.com/news-release/2024/04/22/2867242/0/en/GeneFab-Announces-Two-Presentations-at-the-American-Society-of-Gene-Cell-Therapy-ASGCT-Annual-Meeting-2024.html

GLOBENEWSWIRE
22 Apr 2024
GeneFab debuts, acquires Senti Bio's production tech for $38M
GeneFab debuts, acquires Senti Bio's production tech for $38M

14 Aug 2023

// Fraiser Kansteiner FIERCE PHARMA

https://www.fiercepharma.com/manufacturing/genefab-debuts-manufacturer-acquires-senti-bio-production-tech-38m

Fraiser Kansteiner FIERCE PHARMA
14 Aug 2023

https://www.globenewswire.com/news-release/2023/08/10/2722694/0/en/GeneFab-Launches-to-Offer-Innovative-Manufacturing-and-Synthetic-Biology-Design-Services-for-a-Broad-Range-of-Genetic-Medicines.html

GLOBENEWSWIRE
10 Aug 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty